用于癌症恶病质的草药：系统评价方案
Herbal medicines for cancer cachexia: protocol for a systematic review.
作者信息
Park Bongki, Jun Ji Hee, Jung Jeeyoun, You Sooseong, Lee Myeong Soo
机构信息
Medical Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
出版信息
BMJ Open. 2014 Jun 3;4(6):e005016. doi: 10.1136/bmjopen-2014-005016.
INTRODUCTION
To assess the efficacy of herbal medicines as a treatment of cancer cachexia.
METHODS AND ANALYSIS
We will search the following 13 electronic databases from their inception. MEDLINE (PubMed), the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, Allied and Complementary Medicine Database (AMED), China National Knowledge Infrastructure (CNKI), Wanfang, Journal Integration Platform (VIP) and six Korean Medical Databases (KoreaMed, the Korean Traditional knowledge Portal, OASIS, DBPIA, the Research Information Service System and the Korean Studies Information Service System) without restrictions on time or language. The data will be extracted independently by two authors using predefined criteria. Disagreements will be resolved by discussion between the authors. The risk of bias will be assessed using the Cochrane risk of bias tool.
DISSEMINATION
The review will be published in a journal. The review will also be disseminated electronically and in print. An update of the review will be conducted to inform and guide healthcare practice and policy.
TRIAL REGISTRATION NUMBER
PROSPERO 2013:CRD42013006612.
引言
评估草药治疗癌症恶病质的疗效。
方法与分析
我们将从数据库建立起检索以下13个电子数据库。MEDLINE（PubMed）、Cochrane对照试验中心注册库（CENTRAL）、EMBASE、联合与补充医学数据库（AMED）、中国知网（CNKI）、万方、维普资讯以及六个韩国医学数据库（韩国医学、韩国传统知识门户、绿洲、DBPIA、研究信息服务系统和韩国研究信息服务系统），检索不受时间或语言限制。数据将由两名作者使用预定义标准独立提取。分歧将通过作者之间的讨论解决。将使用Cochrane偏倚风险工具评估偏倚风险。
传播
该综述将发表在期刊上。综述还将以电子和印刷形式传播。将对综述进行更新，以为医疗保健实践和政策提供信息并提供指导。
试验注册号
PROSPERO 2013：CRD42013006612。
Zotero 插件